Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayman Grada

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Drugs in Dermatology : JDD|January 6, 2026
Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United StatesKatrina Abuabara, Christopher G Bunick, Lara Wine Lee, et al.
American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Journal of Drugs in Dermatology : JDD|February 8, 2022
2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and CareFolawiyo Babalola, Cameron Moattari, Brian Berman, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
JAMA Dermatology|June 11, 2020
The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017Melissa R Laughter, Mayra B C Maymone, Chante Karimkhani, et al.
American Journal of Clinical Dermatology|September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 WeeksAlan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
Wilderness & Environmental Medicine|July 14, 2025
Space Oncology: A Comprehensive Scoping ReviewNafise Niknam, Hossein Akbarialiabad, Mohsen Farjoud Kouhanjani, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|January 10, 2020
Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017Juanita A Haagsma, Spencer L James, Chris D Castle, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|August 26, 2020
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 studySpencer L James, Chris D Castle, Zachary V Dingels, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|April 26, 2020
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017Spencer L James, Chris D Castle, Zachary V Dingels, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Drugs in Dermatology : JDD|January 6, 2026
Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United StatesKatrina Abuabara, Christopher G Bunick, Lara Wine Lee, et al.
American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Journal of Drugs in Dermatology : JDD|February 8, 2022
2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and CareFolawiyo Babalola, Cameron Moattari, Brian Berman, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
JAMA Dermatology|June 11, 2020
The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017Melissa R Laughter, Mayra B C Maymone, Chante Karimkhani, et al.
American Journal of Clinical Dermatology|September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 WeeksAlan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
Wilderness & Environmental Medicine|July 14, 2025
Space Oncology: A Comprehensive Scoping ReviewNafise Niknam, Hossein Akbarialiabad, Mohsen Farjoud Kouhanjani, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|January 10, 2020
Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017Juanita A Haagsma, Spencer L James, Chris D Castle, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|August 26, 2020
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 studySpencer L James, Chris D Castle, Zachary V Dingels, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|April 26, 2020
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017Spencer L James, Chris D Castle, Zachary V Dingels, et al.
Pageof 10